Cat Allergy Study

Cliantha Research, Clinical Research Organization (CRO)


The purpose of this study is to identify the best dose of test product: Cat hair allergen which causes allergic symptoms (including sneezing, runny nose, congestion/blockage and itchy nose) in a test called Skin Prick Test (SPT). This test will be used to provide an indication of the effectiveness of cat allergy treatments. No medication will be administered in this study.

Eligibility Criteria


Male, Female

18 to 65 years old

Clinical history of cat allergy

Not have a cat at home or will be regularly exposed to cats

Not have a history of anaphylaxis to cat allergen

Not currently undergoing or have undergone cat immunotherapy within the last 12 months

Other inclusion/exclusion criteria applicable and will be assessed

Study Tasks


Informed Consent Document (ICD)
Medical history and demographics
Measurement of vital signs and physical exam
Skin prick test (SPT)
Nasal exam and nasal provocation test
Other tasks will be outlined during the ICD process
COVID-19 testing will be conducted at designated visit

Ethics


This study has been approved by Advarra Ethics Board

Keywords


clinical trial
cat allergy
allergies
skin prick test

Activity and Time


Investigational Medicine

Clinical Trial

Weekdays, Weekends

15 hours total, 4 sessions

The study visits include General Screening, Visit 1 Medical Screening, COVID-19 testing Visit, and Visit 2, with Visit 1 and Visit 2 being 2 to 30 days apart. The study duration will be approximately 5-6 weeks.

Compensation


Up to $975 

Compensation for General Screening is up to $50, and $925 for study participation upon completion of the study.

Study Address


4500 Dixie Rd Mississauga, Ontario, Canada, L4W 1N2

Posting date: Jan 11, 2021

Earn $975